MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5
2017 · Cell Death and Disease · 91 citations
https://doi.org/10.1038/cddis.2017.561
L
Lulu Wei
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
134
Papers
2.6K
Citations
26
h-index
67
i10-index
Lulu Wei is an academic researcher from Qingdao University of Science and Technology. The author has contributed to research in topics: Chemical Synthesis and Analysis & Metal-Organic Frameworks: Synthesis and Applications & Nanoparticle-Based Drug Delivery. The author has an h-index of 26, co-authored 114 publications.
ORCID: 0000-0003-4657-9479Papers by this author
worksAbnormal expression profile of plasma-derived exosomal microRNAs in patients with treatment-resistant depression
2021 · Human Genomics · 52 citations
https://doi.org/10.1186/s40246-021-00354-z
PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo
2017 · Journal of Experimental & Clinical Cancer Research · 44 citations
https://doi.org/10.1186/s13046-017-0610-5
Disrupted methionine cycle triggers muscle atrophy in cancer cachexia through epigenetic regulation of REDD1
2024 · Cell Metabolism · 34 citations
https://doi.org/10.1016/j.cmet.2024.10.017
An integrative transcriptome study reveals Ddit4/Redd1 as a key regulator of cancer cachexia in rodent models
2021 · Cell Death and Disease · 26 citations
https://doi.org/10.1038/s41419-021-03932-0
Rap2a serves as a potential prognostic indicator of renal cell carcinoma and promotes its migration and invasion through up-regulating p-Akt
2017 · Scientific Reports · 23 citations
https://doi.org/10.1038/s41598-017-06162-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat